Nyhetssvepet fredag 1 december - BioStock - Connecting Innovation and Capital
| BACTIQ Stock | DKK 4.14 0.10 2.36% |
About 62% of Bactiquant's investor base is looking to short. The analysis of current outlook of investing in Bactiquant AS suggests that many traders are alarmed regarding Bactiquant's prospects. The current market sentiment, together with Bactiquant's historical and current headlines, can help investors time the market. In addition, many technical investors use Bactiquant AS stock news signals to limit their universe of possible portfolio assets.
Bactiquant |
Nyhetssvepet fredag 1 december BioStock - Connecting Innovation and Capital
Read at news.google.com
 |
Bactiquant Fundamental Analysis
We analyze Bactiquant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bactiquant using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bactiquant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Bactiquant is rated fifth in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bactiquant AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bactiquant stock to make a market-neutral strategy. Peer analysis of Bactiquant could also be used in its relative valuation, which is a method of valuing Bactiquant by comparing valuation metrics with similar companies.
Peers
Bactiquant Related Equities
| AOJ-B | Broedrene | 4.91 | ||||
| SKJE | Skjern Bank | 0.32 | ||||
| FOM | FOM Technologies | 1.42 | ||||
| BACTIQ | Bactiquant | 2.36 | ||||
| GABR | Gabriel Holding | 2.83 |
Complementary Tools for Bactiquant Stock analysis
When running Bactiquant's price analysis, check to measure Bactiquant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bactiquant is operating at the current time. Most of Bactiquant's value examination focuses on studying past and present price action to predict the probability of Bactiquant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bactiquant's price. Additionally, you may evaluate how the addition of Bactiquant to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |